Saturday, August 13
Ahead of the Bell: Mannkind to start insulin trial - BusinessWeek
Ahead of the Bell: Mannkind to start insulin trial - BusinessWeek: "Shares of MannKind jumped 20 percent before the market opened Friday after the drugmaker said it had confirmed with federal regulators the design of two late-stage clinical trials for its inhaled insulin."
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment